All sponsors

Materia Medica Holding

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-20
ACTIVE TRIALS5
PHASE 3 / 2-35
RECRUITING4
READOUTS ≤12 MONTHS1
Open Materia Medica Holding on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
Raphamin
NCT06284265
P3Active, not recruitingCystitis Chronic; Cystitis Bacterial4152026-12-31
Raphamin
NCT06901297
P3RecruitingRhinosinusitis; Rhinosinusitis Acute5522027-12-31
Raphamin
NCT06715891
P3RecruitingAcute Respiratory Viral Infection3742027-12-31
Rengalin
NCT07171099
P3RecruitingCough2642028-12-31
Raphamin
NCT07650227
P3RecruitingBronchitis; Acute Bronchitis3082028-12-31